EcoDrugPlus

Adenosine A3 Receptor

Ensembl ID : ENSUMAG00000013887
Gene Symbol: ADORA3
2 Cross references
89 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSUMAG00000025440
Gene Symbol: ADA
4 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSUMAG00000003460
Gene Symbol: ADRA1A
4 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSUMAG00000000471
Gene Symbol: ADRA1B
2 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSUMAG00000023764
Gene Symbol: ADRA2A
3 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSUMAG00000012248
Gene Symbol: ADRA2B
1 Cross references
219 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSUMAG00000005490
Gene Symbol: ADRB2
4 Cross references
263 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSUMAG00000010114
Gene Symbol: AGER
1 Cross references
169 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSUMAG00000014946
Gene Symbol: AKR1B1
4 Cross references
427 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSUMAG00000014325
Gene Symbol: GAA
4 Cross references
234 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSUMAG00000018096
Gene Symbol: AOC1
4 Cross references
230 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSUMAG00000025064
Gene Symbol: AOC3
3 Cross references
317 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).